Mercedes Lorite-Montoro
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.
Journal: HemaSphere
Published: December 28, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.
Journal: International journal of molecular sciences
Published: July 31, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.
Journal: HemaSphere
Published: February 25, 2025
Nursing care for chimeric antigen receptor T cell therapy survivors: A literature review.
Journal: Asia-Pacific journal of oncology nursing
Published: December 28, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: September 05, 2023
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Journal: American journal of hematology
Published: December 14, 2021
Integrated Management of Pain in Advanced Dementia.
Journal: Pain management nursing : official journal of the American Society of Pain Management Nurses
Published: March 07, 2018
Quality of diagnosis information given to terminal cancer patients
Journal: Enfermeria clinica
Published: December 07, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026